News | July 26, 2023
Jubilant Ingrevia consolidated Q1 FY2024 PAT up QoQ at Rs. 57.59 Cr
Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023
Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts
If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of HER2-positive advanced gastric or GEJ cancer in tumors expressing PD-L1 (CPS ?1) in the EU
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Subscribe To Our Newsletter & Stay Updated
